Kringle Pharma (TSE:4884) Inventories, Raw Materials & Components: 円250.04 Mil (As of Mar. 2026)


TSE:4884 Kringle Pharma Inc TSE:4884
45 GF Score
Price 円339.00
GF Value 円495.40
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Kringle Pharma Inventories, Raw Materials & Components?

Kringle Pharma TSE:4884 -0.88% 45 Inventories, Raw Materials & Components is 円250.04 Mil as of Mar. 2026. GuruFocus rates TSE:4884 with a GF Score™ of 45/100 and a GF Value™ of 円495.40 (Possible Value Trap). The stock has 5 warning signs investors should review.

Kringle Pharma's inventories, raw materials & components for the quarter that ended in Mar. 2026 was 円250.04 Mil.

Kringle Pharma's quarterly raw materials declined from Sep. 2025 (円250.34 Mil) to Dec. 2025 (円250.10 Mil) and declined from Dec. 2025 (円250.10 Mil) to Mar. 2026 (円250.04 Mil).

Kringle Pharma's annual raw materials declined from Sep. 2023 (円364.06 Mil) to Sep. 2024 (円294.51 Mil) and declined from Sep. 2024 (円294.51 Mil) to Sep. 2025 (円250.34 Mil).

Kringle Pharma Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Kringle Pharma's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kringle Pharma Inventories, Raw Materials & Components Chart

Kringle Pharma Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 226.68 349.88 364.06 294.51 250.34

Kringle Pharma Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 250.41 250.41 250.34 250.10 250.04
TSE:4884
45GF Score
Kringle Pharma Inc TSE:4884
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kringle Pharma Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of 円250.04 Mil mean?
Kringle Pharma (TSE:4884) has a Inventories, Raw Materials & Components of 円250.04 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Kringle Pharma and its competitors.
Is Kringle Pharma's Inventories, Raw Materials & Components too high?
Kringle Pharma's current Inventories, Raw Materials & Components is 円250.04 Mil. Overall, Kringle Pharma has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kringle Pharma's Inventories, Raw Materials & Components compare to VRTX and REGN?
Kringle Pharma's Inventories, Raw Materials & Components of 円250.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Kringle Pharma and its competitors. Kringle Pharma's current Inventories, Raw Materials & Components is 円250.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kringle Pharma stock overvalued right now?
Based on GuruFocus' analysis, Kringle Pharma (TSE:4884) is currently considered Possible Value Trap. The stock's GF Value™ is 円495.40, compared to a current price of 円339.00 — trading 31.6% below its estimated fair value. The current Inventories, Raw Materials & Components is 円250.04 Mil. Kringle Pharma's overall GF Score™ is 45/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Kringle Pharma (TSE:4884), the current Inventories, Raw Materials & Components is 円250.04 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kringle Pharma (TSE:4884) Overvalued in 2026?

Based on GuruFocus' analysis, Kringle Pharma stock appears to be undervalued. The current stock price of 円339.00 is trading 31.6% below its estimated GF Value™ of 円495.40. GuruFocus considers Kringle Pharma to be Possible Value Trap.

Key valuation signals for TSE:4884:

  • Inventories, Raw Materials & Components: 円250.04 Mil
  • GF Value™: 円495.40 vs. price of 円339.00 (31.6% below fair value)
  • GF Score™: 45/100 with 5 warning signs

No single metric tells the full story. See the TSE:4884 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kringle Pharma Business Description

Address 7-7-15 Saito asagi, 207 Saito Bio-Incubator, Osaka Prefecture, Ibaraki, JPN, 567-0085
Kringle Pharma Inc is engaged in the research and development of HGF (hepatocyte growth factor) protein as a therapeutic agent for intractable diseases. The Company operates in a single segment, pharmaceutical development.
45GF Score

Get the complete analysis for TSE:4884

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円339.00
Price
円495.40
GF Value